BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16528046)

  • 41. A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.
    Druillennec S; Dong CZ; Escaich S; Gresh N; Bousseau A; Roques BP; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4886-91. PubMed ID: 10220388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease.
    Wondrak EM; Sakaguchi K; Rice WG; Kun E; Kimmel AR; Louis JM
    J Biol Chem; 1994 Sep; 269(35):21948-50. PubMed ID: 8071314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of the His44 --> Ala single point mutant of the distal finger motif of HIV-1 nucleocapsid protein: a combined NMR, molecular dynamics simulation, and fluorescence study.
    Stote RH; Kellenberger E; Muller H; Bombarda E; Roques BP; Kieffer B; Mély Y
    Biochemistry; 2004 Jun; 43(24):7687-97. PubMed ID: 15196011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro.
    Müller G; Strack B; Dannull J; Sproat BS; Surovoy A; Jung G; Moelling K
    J Mol Biol; 1994 Sep; 242(4):422-9. PubMed ID: 7932701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptase.
    Drummond JE; Mounts P; Gorelick RJ; Casas-Finet JR; Bosche WJ; Henderson LE; Waters DJ; Arthur LO
    AIDS Res Hum Retroviruses; 1997 May; 13(7):533-43. PubMed ID: 9135871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
    Huang M; Orenstein JM; Martin MA; Freed EO
    J Virol; 1995 Nov; 69(11):6810-8. PubMed ID: 7474093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zn(2+) binding properties of single-point mutants of the C-terminal zinc finger of the HIV-1 nucleocapsid protein: evidence of a critical role of cysteine 49 in Zn(2+) dissociation.
    Bombarda E; Cherradi H; Morellet N; Roques BP; Mély Y
    Biochemistry; 2002 Apr; 41(13):4312-20. PubMed ID: 11914077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem.
    Godet J; de Rocquigny H; Raja C; Glasser N; Ficheux D; Darlix JL; Mély Y
    J Mol Biol; 2006 Mar; 356(5):1180-92. PubMed ID: 16406407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides.
    Fisher RJ; Fivash MJ; Stephen AG; Hagan NA; Shenoy SR; Medaglia MV; Smith LR; Worthy KM; Simpson JT; Shoemaker R; McNitt KL; Johnson DG; Hixson CV; Gorelick RJ; Fabris D; Henderson LE; Rein A
    Nucleic Acids Res; 2006; 34(2):472-84. PubMed ID: 16434700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7.
    Beltz H; Azoulay J; Bernacchi S; Clamme JP; Ficheux D; Roques B; Darlix JL; Mély Y
    J Mol Biol; 2003 Apr; 328(1):95-108. PubMed ID: 12684000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific recognition of primer tRNA Lys 3 by HIV-1 nucleocapsid protein: involvement of the zinc fingers and the N-terminal basic extension.
    Tisné C; Roques BP; Dardel F
    Biochimie; 2003 May; 85(5):557-61. PubMed ID: 12763315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases.
    Furuta RA; Shimano R; Ogasawara T; Inubushi R; Amano K; Akari H; Hatanaka M; Kawamura M; Adachi A
    FEBS Lett; 1997 Sep; 415(2):231-4. PubMed ID: 9351002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR.
    Morellet N; de Rocquigny H; Mély Y; Jullian N; Déméné H; Ottmann M; Gérard D; Darlix JL; Fournie-Zaluski MC; Roques BP
    J Mol Biol; 1994 Jan; 235(1):287-301. PubMed ID: 8289249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.
    Liang C; Rong L; Quan Y; Laughrea M; Kleiman L; Wainberg MA
    J Virol; 1999 Aug; 73(8):7014-20. PubMed ID: 10400801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle.
    Lapadat-Tapolsky M; De Rocquigny H; Van Gent D; Roques B; Plasterk R; Darlix JL
    Nucleic Acids Res; 1993 Feb; 21(4):831-9. PubMed ID: 8383840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.